SEC Form 4 · accession 0001209191-18-017344
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alicia Secor
Officer — President and CEO · Director
Period of report
Mar 3, 2018
Accepted (ET)
Mar 6, 2018 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2018 | F | 1,870 | $8.80 | D | 86,355 | D |
Table II — derivative securities
No Table II lines on this filing.